Interestingly, no statistically major difference was noticed between the 84 mg intranasal esketamine plus oral antidepressant dose plus the placebo nasal spray plus oral antidepressant. Sad to say, because the predefined testing sequence constrained testing of review endpoints among fifty six mg intranasal esketamine plus oral antidepressant dose and placebo https://guya233ynb1.wikibriefing.com/user